The clinical significance and oncogenic function of LRRFIP1 in pancreatic cancer
Discover Oncology · 18.04.2024 · 15 (1)
DOI: 10.1007/s12672-024-00977-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Discover Oncology, online erschienen am 18.04.2024. Verfasst von Jinping Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Embryology, School of Preclinical Medicine, Guilin Medical University, Guilin, 541199, Guangxi, People's Republic of Chin…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Funding for National Natural Science Foundation of China, Guangxi Medical and health key cultivation discipline construction project.
Abstract (Originalsprache)
Purpose
Pancreatic cancer is a lethal malignancy with a grim prognosis. Previous studies have proven that Leucine Rich Repeat of Flightless-1 Interacting Protein 1 (LRRFIP1) plays a pivotal role in cell biological processes, while its clinical significance and function in pancreatic cancer remain to be elucidated. Hence, we aimed to explore the roles and mechanisms of LRRFIP1 in pancreatic cancer.
Methods
The expression of LRRFIP1 in pancreatic cancer tissues and its clinical significance for pancreatic cancer were analyzed by immunohistochemistry assay and bioinformatic analysis. The influences of LRRFIP1 on the proliferation and migration of pancreatic cancer cells were assessed in vitro. The underlying mechanisms of LRRFIP1 in pancreatic cancer progression were explored using gene set enrichment analysis (GSEA) and molecular experiments.
Results
The results showed that LRRFIP1 expression was significantly upregulated in pancreatic cancer tissues compared to the normal tissues, and such upregulation was associated with poor prognosis of patients with pancreatic cancer. GSEA revealed that LRRFIP1 upregulation was significantly associated with various cancer-associated signaling pathways, including PI3K/AKT signaling pathway and Wnt pathway. Furthermore, LRRFIP1 was found to be associated with the infiltration of various immune cells. Functionally, LRRFIP1 silencing suppressed cell proliferation somewhat and inhibited migration substantially. Further molecular experiments indicated that LRRFIP1 silencing inactivated the AKT/GSK-3β/β-catenin signaling axis.
Conclusion
Taken together, LRRFIP1 is associated with tumorigenesis, immune cell infiltration, and prognosis in pancreatic cancer, which suggests that LRRFIP1 may be a potential biomarker and therapeutic target for pancreatic cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Histology and Embryology, School of Preclinical Medicine, Guilin Medical University, Guilin, 541199, Guangxi, People's Republic of China. pjli16@glmc.edu.cn.
- Department of Histology and Embryology, School of Preclinical Medicine, Guilin Medical University, Guilin, 541199, Guangxi, People's Republic of China.
- Department of Pathology, Liuzhou People's Hospital, Liuzhou, 545006, Guangxi, People's Republic of China.
- School of Stomatology, Zhaoqing Medical College, Zhaoqing, 526020, Guangdong, People's Republic of China.
- Guangxi Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical University, Guilin, 541199, Guangxi, People's Republic of China. jinfenggan@glmc.edu.cn.
- Department of Gastroenterology, The Second Affiliated Hospital of Guilin Medical University, Guilin, 541199, Guangxi, People's Republic of China. jinfenggan@glmc.edu.cn.
Förderung
- The Funding for National Natural Science Foundation of China
- Guangxi Medical and health key cultivation discipline construction project
Zitieren
APA
Li, J., Tuo, D., Guo, G., Gao, Y., & Gan, J. (2024). The clinical significance and oncogenic function of LRRFIP1 in pancreatic cancer. Discover Oncology, 15(1). https://doi.org/10.1007/s12672-024-00977-3
Vancouver
Li J, Tuo D, Guo G, Gao Y, Gan J. The clinical significance and oncogenic function of LRRFIP1 in pancreatic cancer. Discover Oncology. 2024;15(1). doi:10.1007/s12672-024-00977-3
BibTeX
@article{Li2024,
author = {Li, Jinping and Tuo, Dayun and Guo, Gunan and Gao, Yan and Gan, Jinfeng},
title = {The clinical significance and oncogenic function of LRRFIP1 in pancreatic cancer},
journal = {Discover Oncology},
year = {2024},
volume = {15},
number = {1},
doi = {10.1007/s12672-024-00977-3}
}
EUVIMED